3.25.4 html 436 492 1 false 133 0 false 7 false false R1.htm 75000 - Document - Cover Page Sheet http://karyopharm.com/20251231/taxonomy/role/CoverPage Cover Page Cover 1 false false R2.htm 75010 - Statement - Consolidated Balance Sheets Sheet http://karyopharm.com/20251231/taxonomy/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 75020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://karyopharm.com/20251231/taxonomy/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - Consolidated Statements of Operations Sheet http://karyopharm.com/20251231/taxonomy/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 75040 - Statement - Consolidated Statements of Comprehensive Loss Sheet http://karyopharm.com/20251231/taxonomy/role/ConsolidatedStatementsOfComprehensiveLoss Consolidated Statements of Comprehensive Loss Statements 5 false false R6.htm 75050 - Statement - Consolidated Statements of Stockholders' Deficit Sheet http://karyopharm.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersDeficit Consolidated Statements of Stockholders' Deficit Statements 6 false false R7.htm 75060 - Statement - Consolidated Statements of Cash Flows Sheet http://karyopharm.com/20251231/taxonomy/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 75080 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://karyopharm.com/20251231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 75090 - Disclosure - Cybersecurity Risk Management, Strategy and Governance Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureCybersecurityRiskManagementStrategyAndGovernance Cybersecurity Risk Management, Strategy and Governance Notes 9 false false R10.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 10 false false R11.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 11 false false R12.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 12 false false R13.htm 995457 - Disclosure - Organization and Operations Sheet http://karyopharm.com/20251231/taxonomy/role/OrganizationAndOperations Organization and Operations Notes 13 false false R14.htm 995467 - Disclosure - Summary of Significant Accounting Policies Sheet http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 14 false false R15.htm 995477 - Disclosure - Product Revenue Sheet http://karyopharm.com/20251231/taxonomy/role/ProductRevenue Product Revenue Notes 15 false false R16.htm 995487 - Disclosure - Inventory Sheet http://karyopharm.com/20251231/taxonomy/role/Inventory Inventory Notes 16 false false R17.htm 995497 - Disclosure - License Agreements Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreements License Agreements Notes 17 false false R18.htm 995507 - Disclosure - Fair Value Measurements Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 18 false false R19.htm 995517 - Disclosure - Investments Sheet http://karyopharm.com/20251231/taxonomy/role/Investments Investments Notes 19 false false R20.htm 995527 - Disclosure - Stockholders' Equity Sheet http://karyopharm.com/20251231/taxonomy/role/StockholdersEquity Stockholders' Equity Notes 20 false false R21.htm 995537 - Disclosure - Stock-based Compensation Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensation Stock-based Compensation Notes 21 false false R22.htm 995547 - Disclosure - Long-Term Obligations Sheet http://karyopharm.com/20251231/taxonomy/role/LongTermObligations Long-Term Obligations Notes 22 false false R23.htm 995557 - Disclosure - Common Share Warrants Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureCommonShareWarrants Common Share Warrants Notes 23 false false R24.htm 995567 - Disclosure - Extinguishment Accounting Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccounting Extinguishment Accounting Notes 24 false false R25.htm 995577 - Disclosure - Commitments and Contingencies Sheet http://karyopharm.com/20251231/taxonomy/role/CommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 995587 - Disclosure - Accrued Expenses Sheet http://karyopharm.com/20251231/taxonomy/role/AccruedExpenses Accrued Expenses Notes 26 false false R27.htm 995597 - Disclosure - Property and Equipment, Net Sheet http://karyopharm.com/20251231/taxonomy/role/PropertyAndEquipmentNet Property and Equipment, Net Notes 27 false false R28.htm 995607 - Disclosure - 401(k) Plan Sheet http://karyopharm.com/20251231/taxonomy/role/KPlan 401(k) Plan Notes 28 false false R29.htm 995617 - Disclosure - Income Taxes Sheet http://karyopharm.com/20251231/taxonomy/role/IncomeTaxes Income Taxes Notes 29 false false R30.htm 995627 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPolicies 30 false false R31.htm 995637 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPolicies 31 false false R32.htm 995647 - Disclosure - Product Revenue (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/ProductRevenueTables Product Revenue (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/ProductRevenue 32 false false R33.htm 995657 - Disclosure - Inventory (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/InventoryTables Inventory (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/Inventory 33 false false R34.htm 995667 - Disclosure - License Agreements (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreementsTables License Agreements (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreements 34 false false R35.htm 995677 - Disclosure - Fair Value Measurements (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurements 35 false false R36.htm 995687 - Disclosure - Investments (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/InvestmentsTables Investments (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/Investments 36 false false R37.htm 995697 - Disclosure - Stock-based Compensation (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationTables Stock-based Compensation (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensation 37 false false R38.htm 995707 - Disclosure - Long-Term Obligations (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/LongTermObligationsTables Long-Term Obligations (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/LongTermObligations 38 false false R39.htm 995717 - Disclosure - Common Share Warrants (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureCommonShareWarrantsTables Common Share Warrants (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/DisclosureCommonShareWarrants 39 false false R40.htm 995727 - Disclosure - Extinguishment Accounting (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccountingTables Extinguishment Accounting (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccounting 40 false false R41.htm 995737 - Disclosure - Commitments and Contingencies (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/CommitmentsAndContingencies 41 false false R42.htm 995747 - Disclosure - Accrued Expenses (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/AccruedExpenses 42 false false R43.htm 995757 - Disclosure - Property and Equipment, Net (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/PropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/PropertyAndEquipmentNet 43 false false R44.htm 995767 - Disclosure - Income Taxes (Tables) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://karyopharm.com/20251231/taxonomy/role/IncomeTaxes 44 false false R45.htm 995777 - Disclosure - Organization and Operations - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/OrganizationAndOperationsAdditionalInformationDetail Organization and Operations - Additional Information (Detail) Details 45 false false R46.htm 995787 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 46 false false R47.htm 995797 - Disclosure - Summary of Significant Accounting Policies- Schedule of Revenue and Expense Categories in Single Operating Segment (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueAndExpenseCategoriesInSingleOperatingSegmentDetail Summary of Significant Accounting Policies- Schedule of Revenue and Expense Categories in Single Operating Segment (Detail) Details 47 false false R48.htm 995807 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers that Represent 10% or Greater of our Consolidated Total Revenue (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCustomersThatRepresent10OrGreaterOfOurConsolidatedTotalRevenueDetail Summary of Significant Accounting Policies - Schedule of Customers that Represent 10% or Greater of our Consolidated Total Revenue (Detail) Details 48 false false R49.htm 995817 - Disclosure - Summary of Significant Accounting Policies - Schedule of Customers with Amounts due that Represent 10% or Greater of our Consolidated Accounts Receivable Net Balance (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfCustomersWithAmountsDueThatRepresent10OrGreaterOfOurConsolidatedAccountsReceiva Summary of Significant Accounting Policies - Schedule of Customers with Amounts due that Represent 10% or Greater of our Consolidated Accounts Receivable Net Balance (Detail) Details 49 false false R50.htm 995827 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of the Numerator and Denominator Used to Calculate Diluted Net Loss per Common Share (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfTheNumeratorAndDenominatorUsedToCalculateDilutedNetLossPerCommo Summary of Significant Accounting Policies - Schedule of Reconciliation of the Numerator and Denominator Used to Calculate Diluted Net Loss per Common Share (Detail) Details 50 false false R51.htm 995837 - Disclosure - Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Share Due to their Anti-Dilutive Effect Under the Treasury Method (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfPotentiallyDilutiveSecuritiesWereExcludedFromTheCalculationOfDilutedNetLossPerS Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Securities were Excluded from the Calculation of Diluted Net Loss Per Share Due to their Anti-Dilutive Effect Under the Treasury Method (Detail) Details 51 false false R52.htm 995847 - Disclosure - Product Revenue - Schedule of Product Revenue Allowances Reserve Categories (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/ProductRevenueScheduleOfProductRevenueAllowancesReserveCategoriesDetail Product Revenue - Schedule of Product Revenue Allowances Reserve Categories (Detail) Details 52 false false R53.htm 995857 - Disclosure - Product Revenue - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/ProductRevenueAdditionalInformationDetail Product Revenue - Additional Information (Detail) Details 53 false false R54.htm 995867 - Disclosure - Inventory - Schedule of Inventory Current (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/InventoryScheduleOfInventoryCurrentDetail Inventory - Schedule of Inventory Current (Detail) Details 54 false false R55.htm 995877 - Disclosure - License Agreements - Additional Information - Menarini License Agreement (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationMenariniLicenseAgreementDetail License Agreements - Additional Information - Menarini License Agreement (Detail) Details 55 false false R56.htm 995887 - Disclosure - License Agreements - Additional Information - Antengene License Agreement (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreementsAdditionalInformationAntengeneLicenseAgreementDetail License Agreements - Additional Information - Antengene License Agreement (Detail) Details 56 false false R57.htm 995907 - Disclosure - License Agreements - Schedule of License and Other Revenue (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreementsScheduleOfLicenseAndOtherRevenueDetail License Agreements - Schedule of License and Other Revenue (Detail) Details 57 false false R58.htm 995917 - Disclosure - License Agreements - Summary of License and Other Revenue - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLicenseAgreementsSummaryOfLicenseAndOtherRevenueAdditionalInformationDetail License Agreements - Summary of License and Other Revenue - Additional Information (Detail) Details 58 false false R59.htm 995947 - Disclosure - Fair Value Measurements - Schedule of Financial Assets That Have Been Measured at Fair Value (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsThatHaveBeenMeasuredAtFairValueDetail Fair Value Measurements - Schedule of Financial Assets That Have Been Measured at Fair Value (Detail) Details 59 false false R60.htm 995957 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 60 false false R61.htm 995967 - Disclosure - Fair Value Measurements - Summary of the Changes in the Estimated Fair Value of the Liabilities (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfTheChangesInTheEstimatedFairValueOfTheLiabilitiesDetail Fair Value Measurements - Summary of the Changes in the Estimated Fair Value of the Liabilities (Detail) Details 61 false false R62.htm 995977 - Disclosure - Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/InvestmentsSummaryOfInvestmentsClassifiedAsAvailableForSaleDetail Investments - Summary of Investments, Classified as Available-for-Sale (Detail) Details 62 false false R63.htm 995987 - Disclosure - Investments - Debt Securities Available-For-Sale (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/InvestmentsDebtSecuritiesAvailableForSaleDetail Investments - Debt Securities Available-For-Sale (Detail) Details 63 false false R64.htm 995997 - Disclosure - Investments - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/InvestmentsAdditionalInformationDetail Investments - Additional Information (Detail) Details 64 false false R65.htm 996007 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 65 false false R66.htm 996017 - Disclosure - Stock-based Compensation - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationAdditionalInformationDetail Stock-based Compensation - Additional Information (Detail) Details 66 false false R67.htm 996027 - Disclosure - Stock-based Compensation - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationScheduleOfTotalStockBasedCompensationExpenseRecognizedInConnectionWithAllShareBasedPaymentAwardsDetail Stock-based Compensation - Schedule of Total Stock-based Compensation Expense Recognized in Connection with All Share-based Payment Awards (Detail) Details 67 false false R68.htm 996037 - Disclosure - Stock-based Compensation - Schedule of stock-based compensation expense recognized by award type (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationExpenseRecognizedByAwardTypeDetail Stock-based Compensation - Schedule of stock-based compensation expense recognized by award type (Detail) Details 68 false false R69.htm 996047 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity for Employees and Nonemployees (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationSummaryOfStockOptionActivityForEmployeesAndNonemployeesDetail Stock-based Compensation - Summary of Stock Option Activity for Employees and Nonemployees (Detail) Details 69 false false R70.htm 996057 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Each Employee and Non-employee Stock Award on Grant Date Using Black Scholes Option Pricing Model (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOfEachEmployeeAndNonEmployeeStockAwardOnGrantDateUsingBlackScholesOptionPricingModelDetail Stock-based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Each Employee and Non-employee Stock Award on Grant Date Using Black Scholes Option Pricing Model (Detail) Details 70 false false R71.htm 996067 - Disclosure - Stock-based Compensation - Summary of RSU Activity (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationSummaryOfRsuActivityDetail Stock-based Compensation - Summary of RSU Activity (Detail) Details 71 false false R72.htm 996077 - Disclosure - Stock-based Compensation - Schedule of Assumptions Used to Estimate Fair Value on Grant Date Using Black Scholes Option Pricing Model (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/StockBasedCompensationScheduleOfAssumptionsUsedToEstimateFairValueOnGrantDateUsingBlackScholesOptionPricingModelDetail Stock-based Compensation - Schedule of Assumptions Used to Estimate Fair Value on Grant Date Using Black Scholes Option Pricing Model (Detail) Details 72 false false R73.htm 996087 - Disclosure - Long-Term Obligations - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/LongTermObligationsAdditionalInformationDetail Long-Term Obligations - Additional Information (Detail) Details 73 false false R74.htm 996097 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of 2025 Notes (Detail) Notes http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOf2025NotesDetail Long-Term Obligations - Summary of Outstanding Balances of 2025 Notes (Detail) Details 74 false false R75.htm 996107 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to 2025 Notes (Detail) Notes http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedTo2025NotesDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to 2025 Notes (Detail) Details 75 false false R76.htm 996117 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of Amended Term Loan (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOfAmendedTermLoanDetail Long-Term Obligations - Summary of Outstanding Balances of Amended Term Loan (Detail) Details 76 false false R77.htm 996127 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to Term Loan and Amended Term Loan (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedToTermLoanAndAmendedTermLoanDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to Term Loan and Amended Term Loan (Detail) Details 77 false false R78.htm 996137 - Disclosure - Long-Term Obligations - Summary of Future Minimum Payments on Amended Term Loan (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsSummaryOfFutureMinimumPaymentsOnAmendedTermLoanDetail Long-Term Obligations - Summary of Future Minimum Payments on Amended Term Loan (Detail) Details 78 false false R79.htm 996147 - Disclosure - Long-Term Obligations - Summary of Outstanding Balances of New 2029 Notes, 2029 Notes and 2028 Notes (Detail) Notes http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsSummaryOfOutstandingBalancesOfNew2029Notes2029NotesAnd2028NotesDetail Long-Term Obligations - Summary of Outstanding Balances of New 2029 Notes, 2029 Notes and 2028 Notes (Detail) Details 79 false false R80.htm 996157 - Disclosure - Long-Term Obligations - Schedule of Interest Expense Recognized Related to New 2029 Notes and 2029 Notes (Detail) Notes http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsScheduleOfInterestExpenseRecognizedRelatedToNew2029NotesAnd2029NotesDetail Long-Term Obligations - Schedule of Interest Expense Recognized Related to New 2029 Notes and 2029 Notes (Detail) Details 80 false false R81.htm 996167 - Disclosure - Long-Term Obligations - Summary of Future Minimum Payments on New 2029 Notes and 2028 Notes (Detail) Notes http://karyopharm.com/20251231/taxonomy/role/DisclosureLongtermObligationsSummaryOfFutureMinimumPaymentsOnNew2029NotesAnd2028NotesDetail Long-Term Obligations - Summary of Future Minimum Payments on New 2029 Notes and 2028 Notes (Detail) Details 81 false false R82.htm 996177 - Disclosure - Common Share Warrants - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureCommonShareWarrantsAdditionalInformationDetail Common Share Warrants - Additional Information (Detail) Details 82 false false R83.htm 996187 - Disclosure - Common Share Warrants - Summary of Activity Related to Our Common Stock Warrants (Details) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureCommonShareWarrantsSummaryOfActivityRelatedToOurCommonStockWarrantsDetails Common Share Warrants - Summary of Activity Related to Our Common Stock Warrants (Details) Details 83 false false R84.htm 996197 - Disclosure - Extinguishment Accounting - Additional Information (Details) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccountingAdditionalInformationDetails Extinguishment Accounting - Additional Information (Details) Details 84 false false R85.htm 996207 - Disclosure - Extinguishment Accounting - Summary of Loss on Extinguishment of Debt (Details) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccountingSummaryOfLossOnExtinguishmentOfDebtDetails Extinguishment Accounting - Summary of Loss on Extinguishment of Debt (Details) Details 85 false false R86.htm 996217 - Disclosure - Extinguishment Accounting - Summary of Loss on Extinguishment of Debt for the Extinguishment Holders (Details) Sheet http://karyopharm.com/20251231/taxonomy/role/DisclosureExtinguishmentAccountingSummaryOfLossOnExtinguishmentOfDebtForTheExtinguishmentHoldersDetails Extinguishment Accounting - Summary of Loss on Extinguishment of Debt for the Extinguishment Holders (Details) Details 86 false false R87.htm 996227 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/CommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 87 false false R88.htm 996237 - Disclosure - Commitments and Contingencies - Schedule of Minimum Future Rent Payments Under Lease Agreement (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/CommitmentsAndContingenciesScheduleOfMinimumFutureRentPaymentsUnderLeaseAgreementDetail Commitments and Contingencies - Schedule of Minimum Future Rent Payments Under Lease Agreement (Detail) Details 88 false false R89.htm 996257 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/AccruedExpensesScheduleOfAccruedExpensesDetail Accrued Expenses - Schedule of Accrued Expenses (Detail) Details 89 false false R90.htm 996267 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetail Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Details 90 false false R91.htm 996287 - Disclosure - 401(k) Plan - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/KPlanAdditionalInformationDetail 401(k) Plan - Additional Information (Detail) Details 91 false false R92.htm 996297 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/IncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 92 false false R93.htm 996307 - Disclosure - Income Taxes - Schedule of Components of Income (Loss) Before Income Taxes (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/IncomeTaxesScheduleOfComponentsOfIncomeLossBeforeIncomeTaxesDetail Income Taxes - Schedule of Components of Income (Loss) Before Income Taxes (Detail) Details 93 false false R94.htm 996317 - Disclosure - Income Taxes - Schedule of Significant Components of Company's Deferred Tax Assets (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/IncomeTaxesScheduleOfSignificantComponentsOfCompanysDeferredTaxAssetsDetail Income Taxes - Schedule of Significant Components of Company's Deferred Tax Assets (Detail) Details 94 false false R95.htm 996327 - Disclosure - Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed at Statutory Federal Income Tax Rate to Income Taxes (Detail) Sheet http://karyopharm.com/20251231/taxonomy/role/IncomeTaxesScheduleOfReconciliationOfIncomeTaxExpenseComputedAtStatutoryFederalIncomeTaxRateToIncomeTaxesDetail Income Taxes - Schedule of Reconciliation of Income Tax Expense Computed at Statutory Federal Income Tax Rate to Income Taxes (Detail) Details 95 false false All Reports Book All Reports kpti-20251231.htm kpti-20251231.xsd img70585094_0.jpg img70585094_1.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false